Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin.
Huang XM, Huang JJ, Du JJ, Zhang N, Long Z, Yang Y, Zhong FF, Zheng BW, Shen YF, Huang Z, Qin X, Chen JH, Lin QY, Lin WJ, Ma WZ.
Huang XM, et al. Among authors: lin qy, lin wj.
Acta Pharmacol Sin. 2021 Nov;42(11):1875-1887. doi: 10.1038/s41401-021-00612-9. Epub 2021 Feb 19.
Acta Pharmacol Sin. 2021.
PMID: 33608672
Free PMC article.